External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience CNS 2025
Roche and Genentech at

CNS 2025

October 08 - October 11
Charlotte, USA
childneurologysociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:30 PM
Duration 75mins Charlotte, USA
Real-world use of risdiplam▼ for the treatment of SMA in infants under 2 months of age
N Goedeker, VJ Carson, S Bernes, CC Haws, C Zaidman, C Campos, I Yermilov, MS Broder, E Chang, S Edwards, TL Dickendesher, S Tam, S Shapouri
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:30 PM
Duration 15mins Exhibit Hall (Hall C)
Clinical outcomes among risdiplam▼-treated patients with spinal muscular atrophy (SMA) in the Cure SMA Clinical Data Registry
S Shapouri, TM To, S Whitmire, L Belter, M Schroth, TL Dickendesher, S Tam, R Schuldt
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.